Skip to Main content Skip to Navigation
Journal articles

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study

Celine Dogan 1 Marie de Antonio 1, 2, 3 Dalil Hamroun 4 Hugo Varet 1 Marianne Fabbro 1 Felix Rougier 1 Khadija Amarof 5 Marie-Christine Arne Bes 6 Anne-Laure Bedat-Millet 7 Anthony Behin 8 Remi Bellance 9 Françoise Bouhour 10 Celia Boutte 11 François Boyer 12, 13 Emmanuelle Salort-Campana 14, 15 Françoise Chapon 16, 17 Pascal Cintas 18 Claude Desnuelle 19 Romain Deschamps 9 Valérie Drouin-Garraud 7 Xavier Ferrer 20 Helene Gervais-Bernard 10 Karima Ghorab 21, 22 Pascal Laforêt 23 Armelle Magot 24, 25 Laurent Magy 26, 27 Dominique Menard 28 Marie-Christine Minot 28 Aleksandra Nadaj-Pakleza 29 Sybille Pellieux 30 Yann Péréon 31, 32 Marguerite Preudhomme 33 Jean Pouget 34, 14 Sabrina Sacconi 35, 19 Guilhem Sole 20 Tanya Stojkovich 23 Vincent Tiffreau 33 Andoni Urtizberea 36 Christophe Vial 37 Fabien Zagnoli 38 Gilbert Caranhac Claude Bourlier Gerard Riviere Alain Geille Romain K. Gherardi 1 Bruno Eymard 39 Jack Puymirat Sandrine Katsahian 2 Guillaume Bassez 1
Abstract : BACKGROUND: Myotonic Dystrophy type 1 (DM1) is one of the most heterogeneous hereditary disease in terms of age of onset, clinical manifestations, and severity, challenging both medical management and clinical trials. The CTG expansion size is the main factor determining the age of onset although no factor can finely predict phenotype and prognosis. Differences between males and females have not been specifically reported. Our aim is to study gender impact on DM1 phenotype and severity. METHODS: We first performed cross-sectional analysis of main multiorgan clinical parameters in 1409 adult DM1 patients (\textgreater18y) from the DM-Scope nationwide registry and observed different patterns in males and females. Then, we assessed gender impact on social and economic domains using the AFM-Téléthon DM1 survey (n = 970), and morbidity and mortality using the French National Health Service Database (n = 3301). RESULTS: Men more frequently had (1) severe muscular disability with marked myotonia, muscle weakness, cardiac, and respiratory involvement; (2) developmental abnormalities with facial dysmorphism and cognitive impairment inferred from low educational levels and work in specialized environments; and (3) lonely life. Alternatively, women more frequently had cataracts, dysphagia, digestive tract dysfunction, incontinence, thyroid disorder and obesity. Most differences were out of proportion to those observed in the general population. Compared to women, males were more affected in their social and economic life. In addition, they were more frequently hospitalized for cardiac problems, and had a higher mortality rate. CONCLUSION: Gender is a previously unrecognized factor influencing DM1 clinical profile and severity of the disease, with worse socio-economic consequences of the disease and higher morbidity and mortality in males. Gender should be considered in the design of both stratified medical management and clinical trials
Complete list of metadatas

Cited literature [51 references]  Display  Hide  Download
Contributor : Laurent Jonchère <>
Submitted on : Thursday, September 20, 2018 - 9:57:33 AM
Last modification on : Thursday, December 10, 2020 - 3:44:19 AM
Long-term archiving on: : Friday, December 21, 2018 - 1:25:22 PM


Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License



Celine Dogan, Marie de Antonio, Dalil Hamroun, Hugo Varet, Marianne Fabbro, et al.. Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study. PLoS ONE, Public Library of Science, 2016, 11 (2), pp.e0148264. ⟨10.1371/journal.pone.0148264⟩. ⟨hal-01274908⟩



Record views


Files downloads